Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma Journal Articles Refereed uri icon

Overview

Published in

  • Leukemia and Lymphoma

Time

Date/time value

  • 2013

Identity

Digital Object Identifier (DOI)

  • 10.3109/10428194.2012.746682

Additional Document Info

Parent Title

  • LEUKEMIA & LYMPHOMA

Volume

  • 54

Issue

  • 7

Publisher

  • Harwood Academic Publishing GMBH